Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2013
10/03/2013WO2013147584A1 Antiviral composition against flavivirus
10/03/2013WO2013147509A1 Epitopes of epidermal growth factor receptor surface antigen and use thereof
10/03/2013WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell
10/03/2013WO2013147213A1 Anti-siglec15 antibody with modified cdr
10/03/2013WO2013147212A1 Novel anti-siglec15 antibody
10/03/2013WO2013147176A1 Pharmaceutical composition for treatment and/or prevention of gall bladder cancer
10/03/2013WO2013147169A1 Pharmaceutical composition for treatment and/or prevention of liver cancer
10/03/2013WO2013147153A1 Anti-lamp5 antibody and utilization thereof
10/03/2013WO2013147076A1 FIBROSIS SUPPRESSION BY INHIBITING INTEGRIN α8β1 FUNCTION
10/03/2013WO2013147049A1 Novel artificial lipopeptide
10/03/2013WO2013146319A1 Diabetes-inducible bacterium
10/03/2013WO2013144811A2 Methods and compositions for treating inflammation
10/03/2013WO2013144758A1 Treatment of fibrosis
10/03/2013WO2013144636A1 Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
10/03/2013WO2013144579A1 Use of flagellin as a vaccine
10/03/2013WO2013144563A1 Treatment of acute inflammation in the respiratory tract
10/03/2013WO2013144562A1 Adjuvant
10/03/2013WO2013144412A1 System for conveying antigenic molecules in recombinant polymers similar to elastin
10/03/2013WO2013144355A1 Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
10/03/2013WO2013144266A1 Ang2-binding molecules
10/03/2013WO2013143683A1 Rna formulation for immunotherapy
10/03/2013WO2013143555A1 Rna formulation for immunotherapy
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013WO2013116668A3 Diagnostic peptides for lyme disease
10/03/2013WO2013114339A4 Combination therapy for cancer using hsp27 inhibitor and egfr tyrosine kinase inhibitors or anti-folates
10/03/2013WO2013095738A3 Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins
10/03/2013WO2013078375A3 Administration of alpha4beta7 hetero-dimer-specific antibody
10/03/2013WO2013054307A9 Antibodies and methods for wnt pathway-related diseases
10/03/2013WO2012156975A8 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
10/03/2013WO2012047583A3 Antibodies binding human collagen ii
10/03/2013US20130263297 Methods of treating cancer
10/03/2013US20130261593 Device, System, and Method for Delivery of Sugar Glass Stabilized Compositions
10/03/2013US20130259948 Spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles
10/03/2013US20130259946 Antigenic compositions and methods
10/03/2013US20130259945 Anti-malaria compositions and methods
10/03/2013US20130259929 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
10/03/2013US20130259928 Generation of virosome particles
10/03/2013US20130259900 Adjuvant system for vaccine adjuvant
10/03/2013US20130259898 Vaccine Composition
10/03/2013US20130259896 Stable Immunogenic Compositions of Staphylococcus Aureus Antigens
10/03/2013US20130259891 Use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
10/03/2013US20130259889 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/03/2013US20130259888 Means of controlling infection persistence of helicobacter pylori
10/03/2013US20130259886 Broadly protective influenza t-cell vaccine against diverse influenza a viruses
10/03/2013US20130259883 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
10/03/2013US20130259879 Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
10/03/2013US20130259873 Methods for treating a tumor using an antibody that specifically binds hmw-maa
10/03/2013US20130259871 Human Monoclonal Antibody with Specificity for Dengue Virus Serotype 1 E Protein and Uses Thereof
10/03/2013US20130259859 Ang2-binding molecules
10/03/2013US20130259857 Methods for inhibiting fascin
10/03/2013US20130259831 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-Oxazolo and 3H-Thiazolo[4,5-d]pyrimidin-2-one Compounds and Prodrugs Thereof
10/03/2013US20130259826 Compositions, methods and uses for stimulating immune responses
10/03/2013US20130259799 Human gm-csf antigen binding proteins
10/03/2013CA2875200A1 Fibrosis suppression by inhibiting integrin alpha8beta1 function
10/02/2013EP2644702A1 Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
10/02/2013EP2644698A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
10/02/2013EP2644696A1 Method of increasing replication of a reassortant influenza virus in eggs.
10/02/2013EP2644205A1 Targeting ABCB5 for cancer therapy
10/02/2013EP2644204A2 Combinations of an anti-HER2 antibody-drug conjugate and pertuzumab
10/02/2013EP2644194A2 Combinations of an anti-HER2 antibody-drug conjugate and docetaxel
10/02/2013EP2643698A1 Biomarkers for predicting the efficacy of an immunotherapy against cancer
10/02/2013EP2643354A1 Novel homogeneous humanized antiproliferation antibodies
10/02/2013EP2643350A2 Nk cell modulating treatments and methods for treatment of hematological malignancies
10/02/2013EP2643019A1 Antibodies to notum pectinacetylesterase
10/02/2013EP2643018A2 Anti-il-6 antibodies for the treatment of oral mucositis
10/02/2013EP2643017A1 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
10/02/2013EP2643016A2 Anti-il-6 antibodies for the treatment of anemia
10/02/2013EP2643015A1 Compositions and methods
10/02/2013EP2643014A2 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
10/02/2013EP2642979A1 A pharmaceutical composition
10/02/2013EP2261377B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
10/02/2013EP1562983B1 Multiple variants of meningococcal protein nmb1870
10/02/2013CN103339254A HCV variant with high productivity of infectious hepatitis c virus, and use thereof
10/02/2013CN103339253A TOMM34 peptides and vaccines including the same
10/02/2013CN103339250A Means of controlling infection persistence of Helicobacter pylori
10/02/2013CN103339150A Anti-bradykinin B2 receptor (BKB2R) monoclonal antibody
10/02/2013CN103339145A Carrier immunoglobulins and uses thereof
10/02/2013CN103339143A Hypoallergenic polypeptides for the treatment of house dust mite allergy
10/02/2013CN103338786A Compositions and methods for treating amyloid plaque associated symptoms
10/02/2013CN103338785A Bvdv疫苗 Bvdv vaccine
10/02/2013CN103338779A Pharmaceutical composition for treating cancer
10/02/2013CN103338751A A pharmaceutical composition
10/02/2013CN103333938A Recombinant saccharomyces-fermentum-expressed hepatitis B surface antigen, production method of hepatitis B surface antigen, hepatitis B vaccine and production method of hepatitis B vaccine
10/02/2013CN103333900A Gene for preventing toxoplasma infection and application of gene
10/02/2013CN103333860A Cells producing antibody compositions
10/02/2013CN103333849A Staphylococcus aureus mutant strain, and preparation method and applications thereof
10/02/2013CN103333253A Nano antibody fusion protein, and preparation method and application thereof
10/02/2013CN103333249A PSMA (Prostate Specific Membrane Antigen) monoclonal antibody and applications thereof
10/02/2013CN103333247A Novel monoclonal antibody of VEGFR2 and preparation and application thereof
10/02/2013CN103333242A scFv antibody, encoding gene thereof and application thereof to preparation of preparation for treating or preventing infectious bursal disease
10/02/2013CN103333095A Adipamide D-hydroxyproline derivative and application thereof as nucleic acid vaccine adjuvant
10/02/2013CN103330947A Vaccine for preventing toxoplasma infection and application thereof
10/02/2013CN103330937A Monoclonal antibody-antigen binding segment-T-2 toxin conjugate
10/02/2013CN103330936A Hepatitis B vaccine preparation method using aluminium phosphate adjuvant in-situ method
10/02/2013CN103330935A Application of fructose as vaccine adjuvant
10/02/2013CN103330934A Vibrio anguillarum 01 serotype inactivated vaccine, preparation method and use method thereof
10/02/2013CN102626514B Soft-shelled turtle systemic septicemia spherical virus inactivated vaccine and its preparation method
10/02/2013CN102603898B Fowl adenovirus group I immunity related fusion protein as well as encoding gene and application thereof
10/02/2013CN102258773B Mesylate protein kinase receptor EphA2 dominant epitope compound and preparation method and application thereof
10/02/2013CN101951949B Meningococcal vaccine formulations
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 1823